
Insulin Infusion Pump Market Report 2026
Global Outlook – By Type (Continuous Subcutaneous Insulin Infusion Pumps, Insulin Delivery Pens, Wearable Insulin Pumps), By Technology (Remote Monitoring Systems, Closed Loop Systems, Smart Insulin Pumps), By End Use (Hospitals, Home Care Settings, Diabetes Clinics) - Market Size, Trends, And Global Forecast 2026-2035
Insulin Infusion Pump Market Overview
• Insulin Infusion Pump market size has reached to $6.93 billion in 2025 • Expected to grow to $11.19 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Growing Prevalence Of Diabetes Fuelling The Growth Of The Market Due To Increasing Need For Continuous Glucose Management • Market Trend: Closed-Loop Systems Revolutionize Diabetes Management With Automated Insulin Delivery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Insulin Infusion Pump Market?
Insulin infusion pump is a small, wearable device used for the continuous delivery of insulin to individuals with diabetes, helping to maintain optimal blood glucose levels. It delivers insulin through a catheter placed under the skin, offering more precise and flexible management compared to multiple daily injections. The main types of insulin infusion pumps include continuous subcutaneous insulin infusion pumps, insulin delivery pens, and wearable insulin pumps. Continuous Subcutaneous Insulin Infusion (CSII) pumps refer to medical devices that deliver a steady, continuous dose of rapid-acting insulin through a small catheter placed under the skin. The various technologies involved are remote monitoring systems, closed loop systems, and smart insulin pumps and are used by several end users such as hospitals, home care settings, and diabetes clinics.
What Is The Insulin Infusion Pump Market Size and Share 2026?
The insulin infusion pump market size has grown rapidly in recent years. It will grow from $6.93 billion in 2025 to $7.64 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising prevalence of diabetes globally, limitations of multiple daily insulin injections, advancements in insulin pump technology, increased awareness of intensive insulin therapy, growing adoption of self-monitoring blood glucose.What Is The Insulin Infusion Pump Market Growth Forecast?
The insulin infusion pump market size is expected to see rapid growth in the next few years. It will grow to $11.19 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for automated insulin delivery, rising incidence of type 1 and type 2 diabetes, growing adoption of remote patient monitoring, technological advancements in smart insulin pumps, expanding reimbursement coverage for diabetes devices. Major trends in the forecast period include increasing adoption of continuous glucose-guided insulin delivery, rising preference for wearable and tubeless insulin pumps, growing shift toward home-based diabetes management, expansion of closed-loop and hybrid insulin systems, improved patient adherence through simplified insulin delivery.Global Insulin Infusion Pump Market Segmentation
1) By Type: Continuous Subcutaneous Insulin Infusion Pumps, Insulin Delivery Pens, Wearable Insulin Pumps 2) By Technology: Remote Monitoring Systems, Closed Loop Systems, Smart Insulin Pumps 3) By End Use: Hospitals, Home Care Settings, Diabetes Clinics Subsegments: 1) By Continuous Subcutaneous Insulin Infusion (CSII) Pumps: Tubed Insulin Pumps, Tubeless Insulin Pumps 2) By Insulin Delivery Pens: Reusable Insulin Pens, Disposable Insulin Pens, Smart Insulin Pens 3) By Wearable Insulin Pumps: Adhesive Patch Pumps, Detachable Patch Pumps, Hybrid Closed-Loop WearablesWhat Is The Driver Of The Insulin Infusion Pump Market?
The growing prevalence of diabetes is expected to propel the growth of the insulin infusion pump market going forward. Diabetes is a chronic medical condition where the body is unable to properly regulate blood sugar or glucose levels. The growing prevalence of diabetes is mainly driven by increasing sedentary lifestyles and poor dietary habits that leads to obesity, insulin resistance, and higher rates of type 2 diabetes. Insulin infusion pumps help in diabetes management by delivering continuous and precise insulin doses, maintaining stable blood glucose levels. They reduce the need for frequent injections, offering convenience and better control over blood sugar, enhancing overall diabetes care. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increase in lifestyle-related diseases is expected to drive the growth of the medical device safety testing market.Key Players In The Global Insulin Infusion Pump Market
Major companies operating in the insulin infusion pump market are Roche Holding AG, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Beta Bionics Inc., SOOIL Development Co. Ltd.Global Insulin Infusion Pump Market Trends and Insights
Major companies operating in the insulin infusion pumps market are focusing on developing innovative products, such as insulin patch pump systems, to improve convenience, enhance portability, and provide more discreet and comfortable insulin delivery options for patients. Insulin patch pump systems refer to small, wearable devices that deliver insulin through the skin without the need for traditional tubing. For instance, in November 2023, ViCentra BV, a Netherlands-based medical device company, launched a hybrid closed-loop system for automated insulin delivery that combines its Kaleido insulin patch pump with the Diabeloop DBLG1 algorithm and Dexcom G6 continuous glucose monitoring. This integrated artificial pancreas automatically adjusts insulin dosing in real time, significantly reducing hypoglycemia and improving glucose control and time in range for people with type 1 diabetes. The system is user-friendly, requires minimal setup without fingerstick tests, and uploads data to a cloud platform for easy monitoring by users and healthcare providers.What Are Latest Mergers And Acquisitions In The Insulin Infusion Pump Market?
In May 2023, Medtronic plc, an Ireland-based medical technology company, acquired EO Flow for $738 million. With this acquisition, Medtronic aims to strengthen its diabetes management portfolio by incorporating EOFlow’s innovative wearable insulin delivery technology into its offerings. EOFLOW Co. Ltd. is a South Korea-based medical technology company that focuses on developing wearable and disposable insulin patch pumps to enhance diabetes management.Regional Outlook
North America was the largest region in the insulin infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Insulin Infusion Pump Market?
The insulin infusion pump market consists of revenues earned by entities providing services such as bolus insulin delivery, customizable dosing schedules, and blood glucose monitoring integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The insulin infusion pump market also includes sales of tubed insulin pumps, rechargeable and disposable pump units, smart pump controllers, and integrated CGM-compatible devices designed to improve glycemic control in diabetes patients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Insulin Infusion Pump Market Report 2026?
The insulin infusion pump market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the insulin infusion pump industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Insulin Infusion Pump Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.64 billion |
| Revenue Forecast In 2035 | $11.19 billion |
| Growth Rate | CAGR of 10.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Technology, End Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Roche Holding AG, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Beta Bionics Inc., SOOIL Development Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
